Search

everythinglearnresearchcommunity

for

Search:↓

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Careful management of blood thinners is crucial for lupus patients with APS.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Apremilast did not work for treating severe alopecia areata.

People with vitiligo may have a lower risk of heart disease.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Early diagnosis and treatment are crucial for managing alopecia areata, morphea, and psoriasis.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Talquetamab may cause hair loss and skin issues.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

A 22-year-old with multiple autoimmune diseases needs a multidisciplinary treatment approach.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Hair transplantation can successfully treat stubborn alopecia areata.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Scarred skin in lichen planopilaris loses immune cells due to a decrease in a specific protein in skin cells.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Topical 0.1% tacrolimus significantly improved ear infections in cats.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

CD2 might be a new treatment target for patchy alopecia areata.